The table below shows Fulcrum Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$0.00
$80.00M
$2.81M
$6.34M
$19.16M
$8.82M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$56.10M
$63.39M
$71.80M
$76.78M
$69.70M
$59.04M
SG&A
$28.67M
FULC annual revenue (10-K history)
Fulcrum Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $80.00M in fiscal 2024. Over the 6 fiscal years shown, annual revenue declined from $8.82M (FY 2020) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.